271 results on '"Moghanaki, D."'
Search Results
2. P2.16G.02 "It's Like A Donut!"- Veteran Perspectives of Lung Cancer Screening with Low Dose CT.
3. Biomedical Profiling of Lung Tumor via Ventilation-Induced Tumor Deformation: Implications on the Prognosis of Lung Cancer
4. Enhancing Radiation Therapy Plan Quality in a Multi-Site Randomized Clinical Trial with a Benchmark Credentialing Exercise: The VA STARPORT Experience
5. Incidence of Radiation Pneumonitis Among Patients Treated with Concurrent Thoracic Radiotherapy and Osimertinib for Metastatic Non-Small Cell Lung Cancer
6. EP.07D.02 Comprehensive Treatment Availability is Associated with Improved Outcomes Among Veterans with Early-Stage Lung Cancer Treated at VA Hospitals
7. EP.07B.05 Comparison of Image-Guided Thermal Ablation or Stereotactic Body Radiation Therapy for Primary Non-Small Cell Lung Cancer
8. EP.04A.09 The Impetus, Formation and Initial Strategic Aims of the UCLCC Screening and Prevention Task Force
9. P2.04B.09 A Qualitative Evaluation of the Critical Role of Lung Cancer Screening Program Navigators
10. Deep Dive into the Performance of the 5D Breathing Motion Model
11. Definitions of Local Control after Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer: A Systematic Review of the Literature
12. Longitudinal T-Cell Receptor Analysis of Patients with Locally Advanced NSCLC Treated with Hypofractionated Chemoradiation and SABR Boost
13. A review of rectal toxicity following permanent low dose-rate prostate brachytherapy and the potential value of biodegradable rectal spacers
14. Accounting for Operability Status in Retrospective Comparisons of Surgery vs. SBRT for Early-Stage NSCLC
15. Surgical Outcomes for Early-Stage Non-Small Cell Lung Cancer at Facilities With Stereotactic Body Radiation Therapy Programs
16. Effect of Antibiotic Therapy on Immunotherapy Outcomes for Non-Small Cell Lung Cancer: Analysis From the Veterans Health Administration
17. Lung Cancer Survival Trends in the Veterans Health Administration
18. Toxicity Outcomes After Low-Dose-Rate vs. High-Dose-Rate Brachytherapy Boost in Combination With External Beam Radiation for Intermediate and High-Risk Prostate Cancer
19. FP08.03 Outcomes With Multi-Disciplinary Management of Central Lung Tumors Treated With Percutaneous High-Dose-Rate Brachytherapy
20. P53.08 Concomitant Fibrates and Immunotherapy in Non-Small Cell Lung Cancer Patients in the Veterans Health Administration
21. An International Expert Survey on the Indications and Practice of Radical Thoracic Reirradiation for Non-Small Cell Lung Cancer
22. P05.02 International Delphi Consensus on Radical Thoracic Re-Irradiation for Non-Small Cell Lung Cancer (NSCLC)
23. EP.07B.01 Definitions of Local Control after Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer Reported in the Literature
24. MA02.12 UC Screen California: A Statewide Participatory Informatics Approach to Lung Cancer Screening
25. Influence of Timing Between Androgen Deprivation Therapy and External Beam Radiation Therapy in Patients with Localized, High-Risk Prostate Cancer
26. Systematic Review of Caregivers and Palliative Intent Radiation Therapy: Barriers, Facilitators, Decision Making Needs
27. Palliative Radiotherapy within the Veterans Health Administration: Barriers to Referral and Timeliness of Treatment
28. OA06.03 An Open Source Lung Screening Management System
29. P2.11-33 Organizational Readiness for Implementation of Lung Cancer Screening in a Veterans Affairs Healthcare System
30. Patients with Stage I NSCLC Who Are Not Treated with Either Surgical Resection or Radiation Therapy
31. Comparative Effectiveness of Prostatectomy and Radiation Therapy (RT) in Gleason 9-10 Prostate Cancer
32. Multi-institutional Outcomes of Postprostatectomy Adjuvant Versus Early Salvage Radiation Therapy in Prostate Cancer Patients With Adverse Pathologic Features
33. Prostate Cancer–Specific Mortality and Survival Outcomes for Salvage Radiation Therapy After Radical Prostatectomy
34. Dosimetric Consequences and Acute Toxicity Following Perirectal Hydrogel Spacer Injection During Permanent Prostate Brachytherapy
35. Multiparametric Magnetic Resonance Imaging Guided Salvage Low-Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer—A 15-Year Experience
36. Lung Cancer Specialists’ Opinions on Treatments for Stage I Lung Cancer: A Multidisciplinary Survey
37. Benefit of Elective Nodal Irradiation and Androgen Deprivation Therapy with Postprostatectomy Salvage Radiation Therapy for Prostate Cancer
38. The Effect of Lovastatin on Preservation of Erectile Function After Radiation Therapy (RT) for Prostate Cancer: Secondary Analysis of a Prospective Study
39. The Cost Consequences of Multiparametric MRI-Based Image Surveillance for Gleason’s Score 6 Prostate Cancer
40. Posttreatment Testosterone Levels Do Not Affect Rates of Biochemical Failure in Men Who Have Undergone Definitive Radiation for Prostate Cancer: Implications for Testosterone Replacement
41. Management of Metastatic Spinal Cord Compression Among Veterans Health Administration Radiation Oncologists
42. Dose Response for Salvage Radiation Therapy After Radical Prostatectomy in Margin-Positive Prostate Cancer
43. Contemporary Update of a Multi-institutional Predictive Nomogram for Salvage Radiation Therapy After Prostatectomy
44. Can Stereotactic Ablative Radiation Therapy (SABR) Improve Patient Selection for Lung Cancer Surgery and Reduce Perioperative Mortality?
45. The Emergence of New Late Radiation Toxicities Beyond the Traditional 5 Years of Follow-Up After Low-Dose-Rate Prostate Brachytherapy
46. Long-Term Follow-Up After MRI-Directed Regional Salvage Brachytherapy for Locally Recurrent Adenocarcinoma of the Prostate
47. A Compassionate Care Palliative Radiation Therapy Program for Cancer Patients Enrolled in Hospice: Offering Reduced-Cost Palliative Radiation Therapy in the Same Day as Evaluation
48. Availability of Single-Fraction Palliative Radiation Therapy for Cancer Patients Receiving End-of-Life Care Within the Veterans Healthcare Administration
49. SU‐F‐19A‐07: Is a Day30 Scan Necessary to Evaluate Activity‐Based Regulatory Compliance in Permanent Interstitial Brachytherapy for Prostate Cancer?
50. Short-term Androgen Deprivation Therapy Does Not Cause Long-term Testosterone Suppression or Increased Acute Side Effects in Patients Treated With Brachytherapy for Prostate Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.